Sequential vs concurrent epirubicin and docetaxel as adjuvant chemotherapy for high-risk, node-negative, early breast cancer: an interim analysis of a randomised phase III study from the Hellenic Oncology Research Group

from ! Medicine by Alexandros G. Sfakianakis via alwin on Inoreader http://ift.tt/2t0HU7U
via IFTTT